NovaBone Products received a notice of allowance for a second collagen-related patent from the U.S. Patent and Trademark Office.
Here are four observations:
1. The notice of allowance is for the company's application for its "Devices and Methods for the Regeneration of Bony Defects."
2. This is the second allowance for a collagen/bioactive glass device in the last 90 days.
3. NovaBone Products recently received patent issuance for the first allowance establishing intellectual property for Novabone.
4. The privately held company is a focuses on developing NovaBone, a bioactive synthetic bone graft.